• EGOC · OTC
  • DUSS · OTC
  • CGFIA · OTCQB
  • POTG · OTCQB
  • EMXC · OTC
  • TYTN · OTC
  • TDGI · OTC
  • LUXD · OTCQB
  • NYXO · OTCQB
  • LBAS · OTCQB
  • Tagged SPPH

    OTCBB (SPPH) Spencer Pharmaceutical Receives a $500,000 Non-Refundable Deposit Commitment

    Posted on November 23, 2010 by Jeff Johnson

    SPPH Active on News

    Spencer Pharmaceutical Inc. (SPPH.PK)

    Spencer Pharmaceutical Inc. (Pinksheets:SPPH - News) announced today that it has received an irrevocable commitment for $500,000 in the Company from Al-Dorra. This commitment, the form of which will be determined, will be non-refundable.

    spphAccording to the letter by Al-Dorra, they will forward this commitment on or before November 30, 2010. The non-refundable deposit is intended as a sign of good faith and will enable the company and its independent financial advisors to properly consider the $0.97 offer proposed by Al-Dorra. It should be noted that even though the Company will accept this non-refundable commitment, Company management is obliged by law to review any third party offer presented.

    “This deposit is yet another great gesture by the Al-Dorra group and their interest in our technologies is unparalleled and we look forward to hosting the dinner in their honor,” said Dr. Max Arella, President of Spencer Pharmaceutical Inc. “The $0.97 offer is not yet established but each significant step, such as this investment, brings us further to considering whether such offer is in the best interests of our shareholders,” further added Dr. Arella.

    The final terms and conditions of the transaction will be determined in a definitive agreement. No assurances can be provided that a definitive agreement will be executed. Execution of a definitive agreement is subject to, among other things, confirming due diligence by Spencer, and other conditions and approvals by both companies’ management, board of directors and shareholders, as appropriate.

    About Spencer Pharmaceutical Inc.

    Spencer Pharmaceutical Inc. is a US-based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome. Read the rest of this entry »

    Chronic Inflammation Is Closely Related To Many Diseases And Conditions Associated With Aging

    Posted on by Dana Salvo

    (11/17/10) - Spencer Pharmaceutical Inc. (SPPH) announced that it has released some of its scientific results.

    The company states that chronic inflammation is closely related to many diseases and conditions associated with aging as well as arthritis, gastric reflux disease, colitis, some forms of cancer, Alzheimer’s disease, immune dysfunction, etc. There is a great need for effective treatments that will be simple with no adverse side effects.

    Generally, Ibuprofen (OTC) is rapidly absorbed following oral administration, and possesses a plasma half-life of approximately 2 hours with 80 % of the administered dose excreted in urine. Consequently, the immediate-release dosage of ibuprofen is 200 mg every 4-6 h, with a maximum dosage of 1200 mg over 24 hours. In simple language, there is a big demand on the market for slow release Ibuprofen.

    “Spencer Pharmaceutical has developed such a slow release and unique formulation for NSAIDs controlled release, particularly Ibuprofen, under direct compression on monolithic tablet format, which are able to deliver immediately an effective dosage of the molecule and the remained dosage over a delayed period of 8-10 hours,” stated Dr. Max Arella, CEO of Spencer Pharmaceutical Inc. Furthermore “The matrix (excipient) is based on natural molecules and stabilized under ionic forms. All ingredients are 100 % GRAS (generally approved as safe) and already approved as acceptable substances by FDA,” pointed out Dr. Arella.

    The company also points out, in vitro dissolution showed the novel monolithic tablet (600 mg) of ibuprofen is rapidly delivered in simulated gastric fluid (SGF, pH 2.0) with approximately 25 % released during the first hour and the remaining dosage of ibuprofen is sustained for released over the remaining 10 hours. The easy and non-expensive matrix developed by Spencer Pharmaceutical is currently being submitted for patent protection.

    “We are excited by these new results and we are confident that many applications will be found for this new matrix developed by our scientists,” commented Dr. Max Arella, CEO of Spencer Pharmaceutical. Read the rest of this entry »

    China Stocks Lead Weekly Top 10 Watch List: CHTL, PRGJ, SPPH, MXGD, EMLL

    Posted on November 13, 2010 by Dana Salvo

    China Tel Group OTCBB CHTL heads the weekly top 10 focus list.

    Nov 13th, 2010 Boca Raton, FL– TheStockwizards.net a free hot penny stock pick alert blog newsletter that gives you up to the minute real-time detailed financial information such as CHTL, with quotes and chart updates on the OTC-OTCBB, NYSE, and NASDAQ.

    TheStockWizards.net Weekly Top 10 penny stocks includes: CHTL, PRGJ, SPPH, MXGD, EMLL, ENTI, LFBG, CBAI, MRGP, and DGRI

    Traders and investors are always looking for stocks that are trading near their 52-week lows for a bottom reversal. CHTL has the potential to make a short-term bottom reversal. Volume has increased over the last week as value investors look to snatch up shares at cheap prices. A weekly close above .20 cents could spark a rally in the stock. Any kind of good news could be the catalyst for a short-term run.

    China Tel Group, Inc., through its controlled subsidiaries, provides fixed telephony, conventional long distance, high-speed wireless broadband and telecommunications infrastructure engineering and construction services. ChinaTel is presently building, operating and deploying networks in Asia and South America: a 3.5GHz wireless broadband system in 29 cities across the People’s Republic of China (PRC) with and for CECT-Chinacomm Communications Co., Ltd., a PRC company that holds a license to build the high speed wireless broadband system; and a 2.5GHz wireless broadband system in cities across Peru with and for Perusat, S.A., a Peruvian company that holds a license to build high speed wireless broadband systems. Read the rest of this entry »

    Spencer Pharmaceutical Announces That the Unsolicited All-Cash Buyout Offer at a Premium of $0.97 Per Share

    Posted on November 11, 2010 by Dana Salvo

    OTC Penny Stocks With News SPPH

    spph,otcNov 11th, 2010 Boca Raton, FL–TheStockwizards.net analyzes the most notable explosive OTC, OTCBB, NASDAQ Micro Cap Penny Stocks in the news. OTC Small cap penny stocks includes:  OTC:  SPPH

    Spencer Pharmaceutical Inc. (SPPH.PK)

    BOSTON, MA-Spencer Pharmaceutical Inc. (Pinksheets:SPPH - News) announced today that an unsolicited offer received on November 4, 2010 is at a premium of $0.97 per share, making the potential transaction valued at $245 million.

    According to the buyout offer documents, the purchaser is requiring any and all shares be tendered for a purchase price of $0.97 per share and with the intent to privatize the company. Spencer Pharmaceutical has opted to continue to keep the purchaser’s name confidential until such time as a timeline can be presented and the approval of the board of directors can be obtained. Read the rest of this entry »

    (SPPH,LPTH) OTC Stocks in The News For Nov 1st

    Posted on November 1, 2010 by Dana Salvo

    OTC Penny Stocks With News SPPH, LPTH,

    SPPH,otcNov 1st, 2010 Boca Raton, FL–TheStockwizards.net analyzes the most notable explosive OTC, OTCBB, NASDAQ Micro Cap Penny Stocks in the news. OTC Small cap penny stocks includes:  OTC: LPTH, SPPH

    Spencer Pharmaceutical Inc. (SPPH.PK)

    BOSTON, MA, Nov 01, 2010 Spencer Pharmaceutical Inc. (PINKSHEETS: SPPH) announced today that it has signed a preliminary cooperative development agreement with National Pharmaceutical Corp.According to the agreement, Spencer and National will develop central nervous disease treatments in the areas of Alzheimer and Parkinson using Spencer’s drug delivery as the primary platform. The preliminary agreement calls for a share swap of 20 million restricted shares. The final terms and conditions of the transaction will be determined in a definitive agreement. No assurances can be provided that a definitive agreement will be executed. Execution of a definitive agreement is subject to, among other things, confirming due diligence by Spencer, and other conditions and approvals by both companies’ management, board of directors and shareholders, as appropriate.

    “We are pleased to be working with another group in the development of treatments for CNS related diseases. As many current patented drugs are becoming free of royalties, our technology would extend the patent of treatments in Alzeimers and Parkinsons,” said Dr. Arella, President of Spencer Pharmaceutical Inc. “CNS disease treatments are one of the areas where our technology can be of use in extending the life of the patents, but we are also investigating many other areas such as anti-psychotic and anti-depressor drugs,” further added Dr. Arella.

    About Spencer Pharmaceutical Inc. Spencer Pharmaceutical Inc. is a US-based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome.

    SPENCER PHARMACEUTICAL INC (SPPH:OTC ) Technical Analysis Video Review

    Posted on October 30, 2010 by Joe Torres

    Is SPENCER PHARMACEUTICAL INC (SPPH:OTC ) ready to breakout?


    Read the rest of this entry »

    Pharmaceutical and Medical Optical Stocks SPPH & LPTH Lead Weekly Top 10 For The Coming Week

    Posted on by Dana Salvo

    SPPH  On  Technical Breakout Watch

    spph,otcTheStockWizards.net Weekly Top 10 penny stocks includes: (SPPH:OTC), (LPTH:NASDAQ), (LFBG:OTCBB), (GRNH:OTC), (SFIO:OTC), (LOCN:OTC), (CPTC:OTCBB), (GYPH:OTCBB), (GSLO:OTC), (CRDS:OTC)

    Oct 30, 2010 Boca Raton, FL– TheStockwizards.net a free hot penny stocks picks alert blog newsletter that gives you up to the minute real-time detailed financial information such as SPPH with quotes and chart updates on the OTC-OTCBB, NYSE, and NASDAQ.

    TSW is looking for hot penny stock picks exposed and in play showing unusual movement like SPPH which could be a popular top performing HOT OTC small cap penny stock.

    TSW knows traders and investors are looking for exciting OTC volume movers such as SPPH to put on there speculative penny stock picks watch list for review.

    The TSW penny stock finder trading system locates the best small cap, micro cap penny stocks that have unusual movements with news, popular penny stocks with big gains, and strong stock trends. TSW looks for exciting, explosive penny stocks like LPTH with the right mixture of powerful volume and low market capitalization to give day-traders & investors an opportunity to build a watch list consisting of the most notable penny stocks with positive change that can become explosive mega volume penny picks at any given time. Read the rest of this entry »